Cure Arthritis Naturally

Cure Arthritis Naturally

Get Instant Access

56. Tanaka, H., Abe, E., Miyaura, C., Kuribayashi, T., Konno, K., Nishii, Y., and Suda, T., 1 a,25-dihydroxycholecalciferol and a human myeloid leukaemia cell line, Bio-chem. J., 1982; 204: 713-719.

57. Abe, E., Shiina, Y., Miyaura, C., Tanaka, H., Hayashi, T., Kanegasaki, S., Saito, M., Nishii, Y., DeLuca, H.F., and Suda, T., Activation and fusion induced by 1,25-dihydroxyvitamin D3 and their relation in alveolar macrophages, Proc. Natl. Acad. Sci. U.S.A., 1984; 81: 7112-7116.

58. Bhalla, A.K., Amento, E.P., and Krane, S.M., Differential effects of 1,25-dihydrox-yvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of inter-leukin-2 and augmentation of interleukin-2 and augmentation of interleukin-1 production, Cell. Immunol., 1986; 98: 311-322.

59. Kragballe, K., The future of vitamin D in dermatology, J. Am. Acad. Dermatol., 1997; 37: S72-S76.

60. Bhalla, A.K., Amento, E.P., and Clemens, T.L., Specific high affinity receptors for 1,25 dihydroxy vitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T-lymphocytes following activation, J. Clin. Endocrinol. Metab., 1983; 57: 1308-1310.

61. Rigby, W.F.C. and Waugh, M.G., Decreased accessory cell function and costimulatory activity by 1,25 dihydroxyvitamin D3 treated monocytes, Arthritis Rheum., 1992; 35: 110-119.

62. Gniadecki, R., Gniadecki, M., and Serup, J., Inhibition of glucocorticoid-induced epidermaland dermal atrophy with KH 1060 — a potent 20-epi analogue of 1,25 dihydroxyvitamin D3, Br. Med. Pharmacol., 1994; 113: 439-444.

63. Bikle, D.D. and Pillai, S., Vitamin D, calcium and epidermal differentiation, Endocr. Rev., 1993; 14: 3-19.

64. Chen, T.C., Persons, K., Uskokovic, M.R., Horst, R.L., and Holick, M.F., An evaluation of 1,25-dihydroxyvitamin D3 analogues on the proliferation and differentiation of cultured human keratinocytes, calcium metabolism and the differentiation of human HL-60 cells, J. Nutr. Biochem., 1993; 4: 49-57.

65. Bikle, D.D., Pillai, S., Gee, E., and Hincenbergs, M., Regulation of 1,25-dihydrox-yvitamin D production in human keratinocytes by interferon-gamma, Endocrinology, 1989; 124: 655-660.

66. Smith, E.L., Walworth, N.C., and Holick, M.F., Effect of 1 a,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions, J. Invest. Dermatol., 1986; 86: 709-714.

67. Lutzow-Holm, C., DeAngelis, P., Grosvik, H., and Clausen, O.P., 1,25 dihydroxyvi-tamin D3 analogue KH 1060 induces hyperproliferation in normal mouse epidermis, Exp. Dermatol., 1993; 2: 113-120.

68. Gniadecki, R. and Serup, J., Stimulation of epidermal proliferation in mice with 1,25 dihydroxyvitamin D3 and receptor-active 20-epi analogues of 1,25 dihydroxyvitamin D3, Biochem. Pharmacol., 1995; 49: 621-624.

69. Hosomi, J., Hosoi, J., Abe, E., Suda, T., and Kuroki, T., Regulation of terminal differentiation of mouse cultured epidermal cells by 1,25 dihydroxyvitamin D3, Endocrinology, 1983; 113: 1950-1957.

70. Kato, T., Terui, T., and Tagami, H., Topically active vitamin D3 analogue, 1,24 dihydroxycholecalciferol, has an antiproliferative effect on the epidermis of guinea pig skin, Br. J. Dermatol., 1987; 117: 528-530.

71. Kragballe, K., Steijlen, B., Ibsen, H.H., van de Kerkhof, P.C., Esmann, J., Sorensen, L.H., and Axelsen, M.B., Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization, Arch. Dermatol., 1995; 131: 556-560.

van der Kerhof, P.C., Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms, Br. J. Dermatol., 1995; 132: 675-682. Gurlek, A., Pittelkow, M.R., and Kumar, R., Modulation of growth factor/cytokine synthesis and signaling by 1,25 dihydroxyvitamin D3: implications in cell growth and differentiation, Endocrine Rev., 2002; 23: 763-786.

Bao, B.Y., Hu, Y.C., Ting, H.J., and Lee, Y.F., Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells, Oncogene, 2004; 23: 3350-3360.

Eisman, J.A., Barkla, D.H., and Tutto, J.M., Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25 dihydroxyvitamin D3, Cancer Res., 1987; 47: 21-25.

Bower, M., Colston, K.W., Stein, R.C., Hedley, A., Gazet, J.C., Ford, H.T., and Combes, R.C., Topical calcipotriol treatment in advanced breast cancer, Lancet, 1991; 337: 701-702.

Brown, L.F., Dubin, D., Lavigne, L., Logan, B., Dvorak, H.F., and Van de Water, L., Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing, Am. J. Pathol., 1993; 142: 793-801.

Fransson, J. and Hammar, H., Epidermal growth in the skin equivalent, Arch. Dermatol. Res., 1992; 284: 343-348.

Klein, G.L., Langman, C.B., and Herndon, D.N., Vitamin D depletion following burn injury in children: a possible factor in post-burn osteopenia, J. Trauma, 2002; 52: 346-350. Wray, C.J., Mayes, T., Khoury, J., Warden, G.D., and Gottschlich, M., Metabolic effects of vitamin D on serum calcium, magnesium and phosphorus in pediatric burn patients, J. Burn Care Rehab., 2002; 23: 416-423.

Dawson-Hughes, B., Harris, S.S., Krall, E.A., and Dallal, G.E., Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older, N. Engl. J. Med., 1997; 337: 670-676.

Heubi, J.E., Hollis, B.W., Specker, B., and Tsang, R.C., Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism, Hepatology, 1989; 9: 258-264.

Heubi, J.E., Hollis, B.W., and Tsang, R.C., Bone disease in chronic childhood cholestasis. II. Better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia, Pediatr. Res., 1990; 27: 26-31.

Davies, M., Heys, S.E., Selby, P.L., Berr, J.L., and Mawer, E.B., Increased catabolism of 25-hydroxyvitamin D levels. Implications for metabolic bone disease, J. Clin. Endocrinol. Metab., 1997; 82: 209-212.

Gartner, L.M., Greer, F.R., and the Section on Breast Feeding and Committee on Nutrition, Prevention of rickets and vitamin D deficiency. New guidelines for vitamin D intake, Pediatrics, 2003; 111: 908-910.

Bordier, P., Rasmussen, H., Marie, P., Miravet, L., Gueris, J., and Ryckwaert, A., Vitamin D metabolites and bone mineralization in man, J. Clin. Endocrinol. Metab., 1978; 46: 284-294.

Valimaki, V., Alfthan, H., Lehmuskallio, E., Loyttyniemi, E., Sahi, T., Stenman, U., Suominen, H., and Valimaki, M.J., Vitamin D status as a determinant of peak bone mass in young Finnish men, J. Clin. Endocrinol. Metab., 2004; 89: 76-80. Janssen, H.C.J.P., Samson, M.M., and Verbaar, H.J., Vitamin D deficiency, muscle function, and falls in elderly people, Am. J. Clin. Nutr., 2002; 75: 611-615. Rimaniol, J.M., Authier, F.J., and Chariot, P., Muscle weakness in intensive care patients. Initial manifestation of vitamin D deficiency, Intensive Care Med., 1994; 20: 591-592.

90. Vu, D., Ong, J.M., Clemens, T.L., and Kern, P.A., 1,25-dihydroxyvitamin D induces lipoprotein lipase expression in 3T3-L1 cells in association with adipocyte differentiation, Endocrinology, 1996; 1137: 1540-1544.

91. Hypponen, E., Laara, E., Reunanen, A., Jarvelin, M.R., and Virtanen, S.M., Intake of vitamin D and risk of type I diabetes: a cohort study, Lancet, 2001; 358: 1500-1503.

92. Tsoukas, C.D., Provvedini, D.M., and Manolagas, S.C., 1,25 Dihydroxyvitamin D3: a novel immunoregulatory hormone, Science, 1984; 224: 1438-1439.

93. Manolagas, S.C., Provvedini, D.M., and Tsoukas, C.D., Interaction of 1,25-dihydroxy-vitamin D3 and the immune system, Mol. Cell. Endocrinol., 1985; 43: 113-122.

94. Binderup, L., Latini, S., Binderup, E., Bretting, C., Calverley, M., and Hansen, K., 20-epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses, Biochem. Pharmacol., 1991; 42: 1569-1575.

95. Tsai, A.C., Kelley, J.J., Peng, B., and Cook, N., Study on the effect of megavitamin supplementation in man, Am. J. Clin. Nutr., 1978; 31: 831-837.

96. Kitagawa, M. and Mino, M., Effects of elevated D-(RRR)-tocopherol dosage in man, J. Nutr. Sci. Vitaminol., 1989; 35: 133-142.

97. Vieth, R., Chan, P.C.R., and MacFarlane, G.D., Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level, Am. J. Clin. Nutr., 2001; 73: 288-294.

98. Heaney, R.P., Davies, K.M., Chen, T.C., Holick, M.F., Barger-Lux, M.J., Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol, Am. J. Clin. Nutr., 2003; 77: 204-210.

99. Vieth, R., Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety, Am. J. Clin. Nutr., 1999; 69: 842-856.

100. Hayes, K.C. and Hegsted, D.M., Toxicity of the vitamins, in Committee on Food Protection Toxicants Occurring Naturally in Foods, 2nd ed., National Academy of Sciences, Washington, D.C., 1973; 239-242.

101. American Academy of Pediatrics, The prophylactic requirement and the toxicity of vitamin D, Pediatrics, 1963; 31: 512-523.

102. Adams, J.S., Bone density and vitamin D intoxication, Ann. Intern. Med., 1998; 128: 508.

103. Hinder, R.A. and Stein, H.J., Oxygen-derived free radicals, Arch. Surg., 1991; 124: 104-105.

104. Bieri, J.G., Corash, L., and Hubbard, V.S., Medical uses of vitamin E, N. Engl. J. Med., 1983; 308: 1063-1071.

105. Lopez-Torres, M., Thiele, J.J., Shindo, Y., Han, D., and Packer, L., Topical application of -tocopherol modulates the antioxidant network and diminishes ultraviolet-induced oxidative damage in murine skin, Br. J. Dermatol., 1998; 138: 207-213.

106. Tappel, A.L., Free-radical lipid peroxidation damage and its inhibition by vitamin E and selenium, Fed. Proc., 1965; 24: 73-78.

107. Sata, K., Niki, E., and Shimasaki, H., Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C, Arch. Biochem. Biophys., 1990; 279: 402-405.

108. Nguyen, T.T., Cox, C.S., Traber, D.L., Gasser, H., Ridl, H., Schlag, G., and Herndon, D.N., Free radical activity and loss of plasma antioxidants, vitamin E and sulfhydryl groups in patients with burns, J. Burn Care Rehabil., 1993; 14: 602-609.

109. Williams, R.J., Motteram, J.M., Sharp, C.H., and Gallagher, P.J., Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits, Atherosclerosis, 1992; 94: 153-159.

Jurkiewicz, B.A., Bissett, D.L., and Buettner, G.R., Effect of topically applied tocopherol on ultraviolet radiation-mediated free radical damage in skin, J. Invest. Dermatol., 1995; 104: 484-488.

Sasaki, J., Cottam, G.L., and Baxter, C.R., Lipid peroxidation following thermal injury, J. Burn Care Rehabil, 1983; 4: 251-254.

Mingjian, Z., Qifang, W., Lanxing, G., Hong, J., and Zongyin, W., Comparative observation of the changes in serum lipid peroxides influenced by the supplementation of vitamin E in burn patients and healthy controls, Burns, 1992; 18: 19-21. Brigelius-Flohe, R., Kelly, F.J., Salonen, J.T., Neuzil, J., Zingg, J.M., and Azzi, A., The European perspective on vitamin E: current knowledge and future research, Am. J. Clin. Nutr., 2002; 76: 703-716.

Traber, M.G. and Packer, L., Vitamin E: beyond antioxidant function, Am. J. Clin. Nutr., 1995; 62: 1501S-1509.

Rundus, C., Peterson, V.M., Zapata-Sirvent, R., Hansbrough, J., and Robinson, W.A., Vitamin E improves cell-mediated immunity in the burned mouse: a preliminary study, Burns, 1984; 11: 11-15.

Tanaka, J., Fujiwara, H., and Torisu, M., Vitamin E and immune response: I. Enhancement of helper T-cell activity by dietary supplementation of vitamin E in mice, Immunology, 1979; 38: 727-734.

Violi, F., Pratico, D., Ghiselli, A., Alessandri, C., Iuliano, L., Cordova, C., Balsano, F., Inhibition of cyclooxygenase-independent platelet aggregation by low dose vitamin E concentration, Atherosclerosis, 1990; 82: 247-252.

Steiner, M., Influence of vitamin E on platelet function in humans, J. Am. Coll. Nutr., 1991; 10: 466-473.

Baxter, C.R., Immunologic reactions in chronic wounds, Am. J. Surg., 1994; 167(S): 12-14.

Lee, M., An investigation into the value of d-1-tocopherol acetate (vitamin E) in the treatment of gravitational ulcers, Br. J. Dermatol., 1953; 65: 131-138. Taren, D.L., Chvapil, M., and Weber, C.W., Increasing the breaking strength of wounds exposed to preoperative irradiation using vitamin E supplementation, Int. J. Vit. Nutr. Res., 1987; 57: 133-137.

Melkumian, A.S., Tumanian, E.L., and Agadzhanov, M.I., Histological evaluation of the regenerative capacity of the skin in the treatment of burn wounds with a vitamin E based ointment, Zh. Eksp. Klin. Med., 1978; 18: 52-54.

Vandenboer, H., Schmidt, E., Fajardo, C., Buttler, I., Assis, G., and Vianna, L.M., Effect of a-tocopherol on wound healing, Clin. Nutr., 1999; 18: 59. Baumann, L.S. and Spencer, J., The effects of topical vitamin E on the cosmetic appearance of scars, Dermatol. Surg., 1999; 25: 311-315.

Havlik, R.J., Vitamin E and wound healing, Plast. Reconstr. Surg., 1997; 100: 1901-1902.

Palmieri, G., Vitamin E added silicone gel sheets for treatment of hypertrophic scars and keloids, Int. J. Dermatol., 1995; 34: 506-509.

Jenkins, M., Alexander, J.W., MacMillan, B.G., Waymack, J.P., and Kopcha, R., Failure of topical steroids and vitamin E to reduce postoperative scar formation following reconstructive surgery, J. Burn Care Med., 1986; 7: 309-312. Fisher, A.A., Three faces of vitamin E topical allergy, Cutis, 1991; 48: 272-274. Perrenoud, D., Homberger, H.P., Auderset, P.C., Emmenegger, R., Frenk, E., Saurat, J.H., and Hauser, C., An epidemic outbreak of papular and follicular dermatitis to tocopheryl linoleate in cosmetics, Dermatology, 1994; 189: 225-233.

130. Kelly, F.J. and Sutton, G.L.J., Plasma and red blood cell vitamin E status in patients on total parenteral nutrition, JPEN, 1989; 13: 510-515.

131. Kuroiwa, K., Nelson, J.L., Boyce, S.T., Alexander, J.W., Ogle, C.K., and Inoue, S., Metabolic and immune effect of vitamin E supplementation after burn, JPEN, 1991; 15: 22-26.

132. Horwitt, M.K., Critique of the requirement for vitamin E, Am. J. Clin. Nutr., 2001; 73: 1003-1005.

133. Carpenter, D., Vitamin E deficiency, Sem. Neurol., 1985; 5: 283-287.

134. Sokol, R.J., Vitamin E deficiency and neurologic disease, Ann. Rev. Nutr., 1988; 8: 351-373.

135. Farrell, P.M. and Bieri, J.G., Megavitamin E supplementation in man, Am. J. Clin. Nutr., 1975; 28: 1381-1386.

136. Weber, P., Bendich, A., and Machlin, L., Vitamin E and human health: rationale for determining recommended intake levels, Nutrition, 1997; 13: 450-460.

137. Bendich, A. and Machlin, L.J., Safety of oral intake of vitamin E, Am. J. Clin. Nutr., 1988; 48: 612-619.

138. Kappus, H. and Diplock, A.T., Tolerance and safety of vitamin E: a toxicological position report, Free Rad. Biol. Med., 1992; 13: 55-74.

139. Goodson, W.H. and Hunt, T.K., Wound healing, in Nutrition and Metabolism in Patient Care, Kinney, J.M., Jeejeebhoy, K.N., and Hill, G.L., Eds., W.B. Saunders, Philadelphia, 1988: 635-642.

140. de la Rubia, J., Grau, E., Montserrat, I., Zuazu, I., and Paya, A., Anaphylactic shock and vitamin K [letter], Ann. Intern. Med., 1989; 110: 943.

141. Bossee, G.M., Mallory, M.N., and Malone, G.J., The safety of intravenously administered vitamin K, Vet. Hum. Toxicol., 2002; 44: 174-176.

142. Shevchuk, Y.M. and Conly, J.M., Antibiotic-associated hypoprothrombinemia: a review of prospective studies 1966-1988, Rev. Infect. Dis., 1990; 12: 1109-1126.

143. Shearer, M.J., Bechtold, H., Andrassy, K., Koderisch, J., McCarthy, P.T., Trenk, K., Jahnchen, E., and Ritz, E., Mechanism of cephalosporin-induced hypoprothrombine-mia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status, J. Clin. Pharmacol., 1988; 28: 88-95.

144. Rai, K. and Courtemanche, A.D., Vitamin A assay in burned patients, J. Trauma, 1975; 15: 419-424.

145. Cynober, L., Desmoulins, D., Lioret, N., Aussel, C., Hirsch-Marie, H., and Saizy, R., Significance of vitamin A and retinol binding protein serum levels after burn injury, Clin. Chim. Acta, 1985; 148: 247-253.

146. Rock, C.L., Dechert, R.E., Khilnani, R., Parker, R.S., and Rodriguez, J.L., Caro-tenoids and antioxidant vitamins in patients after burn injury, J. Burn Care Rehabil., 1997; 18: 269-278.

147. Szebeni, A., Negyesi, G., and Feuer, L., Vitamin A levels in the serum of burned patients, Burns, 1980; 7: 313-318.

148. Rojas, A.I. and Phillips, T.J., Patients with chronic leg ulcers show diminished levels of vitamins A and E, carotenes, and zinc, Dermatol. Surg., 1999; 25: 601-604.

149. Thomas, M.K., Lloyd Jones, D.M., Thadhani, R.I., Shaw, A.C., Deraska, D.J., Kitch, B.T., Vamvakas, E.C., Dick, I.M., Prince, R.L., and Finkelstein, J.S., Hypovitaminosis D in medical inpatients, N. Engl. J. Med., 1998; 338: 777-783.

150. Freaney, R., McBrinn, Y., and McKenna, M.J., Secondary hyperparathyroidism in elderly people: combined effect of renal insufficiency and vitamin D deficiency, Am. J. Clin. Nutr., 1993; 58: 187-191.

Jacques, P.F., Felson, D.T., Tucker, K.L., Mahnken, B., Wilson, P.W., Rosenberg, I.H., and Rush, D., Plasma 25-hydroxyvitamin D and its determinants in an elderly population, Am. J. Clin. Nutr., 1997; 66: 929-936.

MacLaughlin, J. and Holick, M.F., Aging decreases capacity of human skin to produce vitamin D3, J. Clin. Invest., 1985; 76: 1536-1538.

Klein, G.L., Horst, R.L., and Norman, A.W., Reduced serum levels of 1,25-dihydroxy-vitamin D during long term total parenteral nutrition, Ann. Intern. Med., 1981; 94: 638-643.

Shike, M., Harrison, J.E., Sturtridge, W.C., Tam, C.S., Bobechko, P.E., Jones, G., Murray, T.M., and Jeejeebhoy, K.N., Metabolic bone disease in patients receiving long term total parenteral nutrition, Ann. Intern. Med., 1980; 92: 343-350. Baer, M.T., Kozlowski, B.W., Blyler, E.M., Trahms, C.M., Taylor, M.L., and Hogan, M.P., Vitamin D, calcium and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status, Am. J. Clin. Nutr., 1997; 65: 1042-1051.

Buckley, L.M., Leib, E.S., Cartularo, K.S., Vacek, P.M., and Cooper, S.M., Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low dose corticosteroids in patients with rheumatoid arthritis, Ann. Intern. Med., 1996; 125: 961-968.

Sambrook, P., Birmingham, J., Kelly, P., Kempler, S., Nguyen, T., Pocock, N., and Eisman, J., Prevention of corticosteroid osteoporosis: a comparison of calcium, cal-citriol, and calcitonin, N. Engl. J. Med., 1993; 328: 1747-1752. Barnes, T.C. and Bucknall, R.C., Vitamin D deficiency in a patient with systemic lupus every thematosus, Rheumatology, 2004; 43: 393-394.

Mayes, T., Gottschlich, M.M., James, L., and Warden, G.D., An evaluation of the relationship between protein status and vitamin D nutriture in burned infants, J. Burn Care Rehabil., 2004; 25: S147.

Cannata-Andia, J.B. and Alonso, C.G., Vitamin D deficiency: a neglected aspect of disturbed calcium metabolism in renal failure, Nephrol. Dial. Transplant, 2002; 17: 1875-1878.

Wilson, L., Felsenfeld, A., Drezner, M.K., and Llach, F., Altered divalent ion metabolism inearly renal failure: role of 1,25(OH)2D, Kidney Int., 1985; 27: 565-573. Rosen, J.F. and Chesney, R.W., Circulating calcitriol concentrations in health and disease, J. Pediatr., 1983; 103: 1-17.

Compston, J.E., Ayers, A.B., Horton, L.W., Tighe, J.R., and Creamer, B., Osteomalacia after small intestinal resection, Lancet, 1978; 1: 9-12.

Lo, C.W., Paris, P.W., Clemens, T.L., Nolan, J., and Holick, M.F., Vitamin D absorption in healthy subjects and in in-patients with intestinal malabsorption syndromes, Am. J. Clin. Nutr., 1985; 42: 644-649.

Vandewoude, M.G., Vandewoude, M.F.J., and DeLeeuw, I.H., Vitamin E status in patients on parenteral nutrition receiving Intralipid, JPEN, 1986; 10: 303-305. Lloyd, J.K., The importance of vitamin E in human nutrition, Acta Pediatr. Scand., 1990; 79: 6-11.

Shukla, A., Rasik, A.M., and Patnaik, G.K., Depletion of reduced glutathione, ascorbic acid, vitamin E and antioxidant defence enzymes in a healing cutaneous wound, Free Radic. Res., 1997; 26: 93-101.

Gupta, A., Singh, R.L., and Raghubir, R., Antioxidant status during cutaneous wound healing in immunocompromised rats, Mol. Cell. Biochem., 2002; 241: 1-7.

169. Jenkins, M.E., Gottschlich, M.M., Kopcha, R., Khoury, J., and Warden, G.D., A prospective analysis of serum vitamin K in severely burned pediatric patients, J. Burn Care Rehabil, 1998; 19: 75-81.

170. Alperin, J.B., Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients, JAMA, 1987; 258: 1916-1919.

171. Shevchuk, Y.M. and Conly, J.M., Antibiotic-associated hypoprothrombinemia: a review of prospective studies 1966-1988, Rev. Infect. Dis., 1990; 12: 1109-1126.

172. Conly, J.M., Ramotar, K., Chubb, H., Bow, E.J., and Louie, T.J., Hyproprothrom-binemia in febrile, neutropenic patients with cancer: association with antimicrobial suppression of intestinal microflora, J. Infect. Dis., 1984; 150: 202-212.

173. Carlin, A. and Walker, W.A., Rapid development of vitamin K deficiency in an adolescent boy receiving total parenteral nutrition following bone marrow transplantation, Nutr. Rev., 1991; 49: 179-183.

174. Allison, P.M., Mummah-Schendel, L.L., Kindberg, C.G., Harms, C.S., Bang, N.U., and Suttie, J.W., Effects of a vitamin K-deficient diet and antibiotics in normal human volunteers, J. Lab. Clin. Med., 1987; 110: 180-188.

175. Bhat, R.V. and Deshmukh, C.T., A study of vitamin K status in children on prolonged antibiotic therapy, Indian Pediatr., 2003; 40: 36-40.

176. Ansell, J.E., Kumar, R., and Deykin, D., The spectrum of vitamin K deficiency, JAMA, 1977; 238: 40-42.

177. Verghese, T. and Beverley, D., Vitamin K deficient bleeding in cystic fibrosis, Arch. Dis. Child, 2003; 88: 553-555.

Was this article helpful?

0 0
Natural Arthritis Relief

Natural Arthritis Relief

Natural Arthritis Relief details a unique method of reversing Rheumatoid Arthritis Symptoms by removing numerous arthritis triggers as well as toxins using a simple 5 step natural process.

Get My Free Ebook

Post a comment